Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ligand Pharmaceuticals Inc.    LGND

News SummaryMost relevantAll newsSector newsTweets

Ligand Pharmaceuticals Inc. : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated

share with twitter share with LinkedIn share with facebook
share via e-mail
05/17/2013 | 06:55pm CEST

NEW YORK, May 17, 2013 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Ligand Pharmaceuticals Incorporated (NasdaqGM: LGND), and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

To get more information, click here: http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/. There is no cost or obligation to you.

If you own common stock in Ligand Pharmaceuticals Incorporated and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171

SOURCE Levi & Korsinsky, LLP

share with twitter share with LinkedIn share with facebook
share via e-mail
10/10 LIGAND PHARMACEUTICALS INC : Other Events (form 8-K)
10/06 LIGAND PHARMACEUTICALS : to Acquire Crystal Bioscience, the Leader in Chicken de..
10/04 LIGAND PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Regulat..
10/04 LIGAND PHARMACEUTICALS : to Acquire Crystal Bioscience, the Leader in Chicken-de..
09/27 VIKING THERAPEUTICS : to Host Key Opinion Leader Event to Discuss Musculoskeleta..
09/27 LIGAND PHARMACEUTICALS : to Host Analyst Day on November 14th in New York City
09/25 LIGAND PHARMACEUTICALS : to Host Analyst Day on November 14th in New York City
09/14 LIGAND PHARMACEUTICALS : Announces Top-Line Results from Phase 2 Study of LGD-69..
09/07 LIGAND PHARMACEUTICALS : Announces Top Line Results from Phase 2 Study of LGD 69..
09/07 LIGAND PHARMACEUTICALS : Diabetes drug results positive, Ligand says
More news
News from SeekingAlpha
10/19 BIOTECH DEVELOPER STOCKS : What Are The Best Wealth-Builders Now?
10/19 YOUR DAILY PHARMA SCOOP : Gilead's Brave New World, AZN's Lynparza SNDA, RXDX En..
10/17 VIKING THERAPEUTICS : Conquering The Market For Aging Therapies
10/12 YOUR DAILY PHARMA SCOOP : AcelRx DSUVIA PDUFA, Ardelyx Phase 3 Success, Rhopress..
10/06 YOUR DAILY PHARMA SCOOP : Gilead, Some History; Biogen's Spinraza, MDCO New Data..